Drug Type Mesenchymal stem cell therapy |
Synonyms Bone marrowderived mesenchymal stem cells |
Target- |
Mechanism Cell replacements |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple System Atrophy | Phase 1 | KR | 13 Aug 2018 |